IL-1 is elevated in experimental glomerular disease and administration of IL-1 accentuates the renal injury, associated with directly stimulating the proliferation of mesangial cells, as well as indirectly exacerbating injury by increasing the production of other inflammatory mediators such as IL-6, TNF-α and ICAM [59]–[61]. This evidence concerns the gene TNF and glomerular disorder.